COVID-19 and alcohol liver disease (literature review)


DOI: https://dx.doi.org/10.18565/therapy.2024.3.82-87

Usanova A.A., Novikova E.K., Kuzma F.M., Sergutova N.P.

N.P. Ogarev National Research Mordovia State University, Saransk
Abstract. During the new coronavirus pandemic, alcohol abuse among adults has significantly increased. Lack of social activities and social support, isolation from society are among the influencing factors. Analyzing the impact of SARS-CoV-2 at the human body, it is worth to note that, in addition to damaging the respiratory system, the virus can also damage other organs and systems, including digestive system. Enhancing the aggressive effect of coronavirus at the human body, ethanol worsens clinical course and prognosis of the disease. For timely diagnosing of COVID-19, prescribing correct treatment tactics and preventing the development of complications in patients with alcoholic liver disease, the interaction of an entire team of specialists is required.
Keywords: pandemic, new coronavirus infection, virus, liver, alcoholism, alcoholic liver disease
Read entire article

Literature

1. Алиева С.А., Никитин И.Г. Неалкогольная жировая болезнь печени как предиктор неблагоприятного течения COVID-19. Лечебное дело. 2022; (2): 50–55. (Alieva S.A., Nikitin I.G. Non-alcoholic fatty liver disease as a predictor of the unfavorable course of COVID-19 infection. Lechebnoe delo = General Medicine. 2022; (2): 50–55 (In Russ.)).


https://doi.org/10.24412/2071-5315-2022-12806. EDN: ZGNWAI.


2. Усанова А.А., Кузма Ф., Гуранова Н.Н., Новикова Э.К. Современные неинвазивные методы диагностики алкогольной болезни печени. Медицина и физическая культура: наука и практика. 2019; 1(1): 34–43. (Usanova A.A., Kuzma F., Guranova N.N., Novikova E.K. Alcoholic liver disease modern noninvasive diagnostics methods. Meditsina i fizicheskaya kul’tura: nauka i praktika = Medicine and Physical Education: Science and Practice. 2019; 1(1): 34–43 (In Russ.)). EDN: BFHOEG.


3. Усанова А.А., Павлов Ч.С., Кузма Ф.М., Новикова Э.К. Биопсия печени – «золотой стандарт» в диагностике алкогольной болезни печени. Современные проблемы науки и образования. 2021; (5): 118. (Usanova A.A., Pavlov Ch.S., Kuzma F.M., Novikova E.K. Liver biopsy is the “gold standard” in the diagnosis of alcoholic liver disease. Sovremennyye problemy nauki i obrazovaniya = Modern Problems of Science and Education. 2021; (5): 118 (In Russ.)). EDN: WDQDOK.


4. Dos Santos S.G.R., Mattos A.A., Guimaraes M.M. et al. Alcohol consumption influences clinical outcome in patients admitted to a referral center for liver disease. Ann Hepatol. 2018; 17(3): 470–75.


https://doi.org/10.5604/01.3001.0011.7391. PMID: 29735785.


5. Lippi G., Favaloro E.J. D-dimer is associated with severity of coronavirus disease 2019: A pooled analysis. J Thromb Haemost. 2020; 120(5): 876–78.


https://doi.org/10.1055/s-0040-1709650. PMID: 32246450. PMCID: PMC7295300.


6. Ge J., Pletcher M., Lai J.; N3C Consortium. Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: A national COVID cohort collaborative study. Gastroenterology. 2021; 161(5): 1487–501.e5.


https://doi.org/10.1053/j.gastro.2021.07.010. PMID: 34284037. PMCID: PMC8286237.


7. Dawood R., Salum G., El-Meguid M. The impact of COVID-19 on liver injury. J Med Sci. 2021; 363(2): 94–103.


https://doi.org/10.1016/j.amjms.2021.11.001. PMID: 34752738. PMCID: PMC8571104.


8. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. COVID-19 и поражение печени. Архивъ внутренней медицины. 2020; 10(3): 188–197. (Ilchenko L.Yu., Nikitin I.G., Fedorov I.G. COVID-19 and liver damage. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2020; 10(3): 188–197 (In Russ.)).


https://doi.org/10.20514/2226-6704-2020-10-3-188-197. EDN: ABJPTS.


9. Кузма Ф., Павлов Ч.С., Усанова А.А. с соавт. Неинвазивные и лабораторные методы диагностики алкогольной болезни печени: литературный обзор. Гастроэнтерология. Приложение к журналу Consilium Medicum. 2017; (2): 27–32. (Kuzma F., Pavlov Ch.S., Usanova A.A. et al. Noninvasive and laboratory methods of diagnosis alcoholic liver disease: Literature review. Gastroenterologiya. Prilozheniye k zhurnalu Consilium Medicum = Gastroenterology. Supplement to Consilium Medicum. 2017; (2): 27–32 (In Russ.)).


https://doi.org/10.26442/2075-1753_19.8.2.27-32. EDN: ZTUTDD.


10. Roshanshad R., Roshanshad A., Fereidooni R., Hosseini-Bensenjan M. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations. World J Hepatol. 2023; 15(4): 441–59.


https://doi.org/10.4254/wjh.v15.i4.441. PMID: 37206656. PMCID: PMC10190688.


11. Elnaggar M., Abomhya A., Elkhattib I. et al. COVID-19 and liver diseases, what we know so far. World J Clin Cases. 2022; 10(13): 3969–80.


https://doi.org/10.12998/wjcc.v10.i13.3969. PMID: 35665122. PMCID: PMC9131221.


12. Mehta P., McAuley D.F., Brown M. et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229): 1033–34.


https://doi.org/10.1016/S0140-6736(20)30628-0. PMID: 32192578. PMCID: PMC7270045.


13. Петров В.И., Пономарева А.В., Ивахненко И.В. с соавт. Этиопатогенетические аспекты повреждения печени у пациентов с COVID-19. Вестник Волгоградского государственного медицинского университета. 2020; 4(76): 9–15. (Petrov V.I., Ponomareva A.V., Ivakhnenko I.V. et al. Etiopathogenetic aspects of liver injury in patients with COVID-19. 2020; 4(76): 9–15 (In Russ.)).


https://doi.org/10.19163/1994-9480-2020-4(76)-9-15. EDN: CMMLNT.


14. Marano G., Traversi G., Gaetani E. et al. Alcohol use disorder and liver injury related to the COVID-19 pandemic. World J Hepatol. 2022; 14(10): 1875–83.


https://doi.org/10.4254/wjh.v14.i10.1875. PMID: 36340751. PMCID: PMC9627438.


15. Amin M. COVID-19 and the liver: Overview. J Gastroenterol Hepatol. 2021; 3(33): 309–11.


https://doi.org/10.1097/MEG.0000000000001808. PMID: 32558697. PMCID: PMC7846245.


16. Никитин И.Г., Ильченко Л.Ю., Федоров И.Г., Тотолян Г.Г. Поражение печени при COVID-19: два клинических наблюдения. Альманах клинической медицины. 2020; 48(6): 412–421. (Nikitin I.G., Ilchenko L.Yu., Fedorov I.G., Totolyan G.G. Liver injury in COVID-19: Two clinical cases. Al’manakh klinicheskoy meditsiny = Almanac of Clinical Medicine. 2020; 48(6): 412–421 (In Russ.)).


https://doi.org/10.18786/2072-0505-2020-48-053. EDN: EULZKL.


17. Wang X., Zhou Y., Jiang N. et al. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int J Infect Dis. 2020; 95: 433–35.


https://doi.org/10.1016/j.ijid.2020.04.063. PMID: 32353545. PMCID: PMC7184976.


18. Johns Hopkins University. COVID-19 Data Visualization Center. New cases of COVID-19 In world countries. 2021. URL: https://coronavirus.jhu.edu/data/new-cases (date of access – 01.04.2024).


19. Усанова А.А., Павлов Ч.С., Кузма Ф.М. с соавт. Актуальность и эпидемиология алкогольной болезни печени. Современные проблемы науки и образования. 2023; (1): 87. (Usanova A.A., Pavlov Ch.S., Kuzma F.M. et al. Relevance and epidemiology of alcoholic liver disease. Sovremennyye problemy nauki i obrazovaniya = Modern Problems of Science and Education. 2023; (1): 87 (In Russ.)).


https://doi.org/10.17513/spno.32337. EDN: BSDATG.


20. World Health Organization. Global status report on alcohol and health. 2018. URL: https://www.who.int/publications/i/item/9789241565639 (date of access – 01.04.2024).


21. Кудашкина Е.Ю., Ильченко Л.Ю., Федоров И.Г. Течение алкогольного цирроза печени у пациента с COVID-19. Архивъ внутренней медицины. 2022; 12(3): 234–240. (Kudashkina E.Yu., Ilchenko L.Yu., Fedorov I.G. The course of alcoholic cirrhosis of the liver in a patient with COVID-19. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2022; 12(3): 234–240 (In Russ.)).


https://doi.org/10.20514/2226-6704-2022-12-3-234-239. EDN: YUXAUO.


22. Marjot T., Moon A., Cook J. et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2021; 74(3): 567–77.


https://doi.org/10.1016/j.jhep.2020.09.024. PMID: 33035628. PMCID: PMC7536538.


23. Esra G., Gu W., Trebicka J. Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: Another collateral damage of the COVID-19 pandemic? 2022; 71(5): 1036–38.


https://doi.org/10.1136/gutjnl-2021-325278. PMID: 35396231. PMCID: PMC8995809.


24. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020; 382(18): 1708–20.


https://doi.org/10.1056/NEJMoa2002032. PMID: 32109013. PMCID: PMC7092819.


25. Deutsch-Link S., Curtis B., Singal A.K. Covid-19 and alcohol associated liver disease. Dig Liver Dis. 2022; 54(11): 1459–68.


https://doi.org/10.1016/j.dld.2022.07.007. PMID: 35933291. PMCID: PMC9349236.


26. Arachchillage D.R.J., Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(5): 1233–34.


https://doi.org/10.1111/jth.14820. PMID: 32291954. PMCID: PMC7262191.


27. Xydakis M.S., Dehgani-Mobaraki P., Holbrook E.H. et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect. 2020; 20(4): 1015–16.


https://doi.org/10.1016/S1473-3099(20)30293-0. PMID: 32304629. PMCID: PMC7159875.


About the Autors

Anna A. Usanova, MD, Dr. Sci. (Medicine), professor, head of the Department of faculty therapy with a course of medical rehabilitation, N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68/1 Bolshevikskaya St.
E-mail: anna61-u@mail.ru
ORCID: https://orcid.org/0000-0003-2948-4865
Elvira K. Novikova, MD, assistant at the Department of faculty therapy with a course of medical rehabilitation,
N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68/1 Bolshevikskaya St.
E-mail: Elja_F@mail.ru
ORCID: https://orcid.org/0000-0002-2839-8984
Fadi M. Kuzma, MD, senior lecturer of the Department of faculty therapy with a course of medical rehabilitation,
N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68/1 Bolshevikskaya St.
E-mail: fadykuzma@mail.ru
ORCID: https://orcid.org/0000-0002-5215-0196
Natalya P. Sergutova, MD, PhD (Medicine), associate professor of the Department of faculty therapy with a course of medical rehabilitation, N.P. Ogarev National Research Mordovia State University. Address: 430005, Saransk, 68/1 Bolshevikskaya St.
E-mail: sergutovanp@mail.ru
ORCID: https://orcid.org/0000-0001-8274-7906


Similar Articles

Back to Content

Бионика Медиа